Treatment with salidroside enhanced skeletal muscle cells–endothelial and/or smooth muscle cells communication mediated by VEGF-A and PDGF-BB, and in turn, enhanced the proliferation and migration potentials of endothelial and smooth muscle cells under hyperglycemia. The gene discussed is VEGFA; the disease is Hyperglycemia.